NEW YORK (GenomeWeb) – Genoptix has acquired the rights to market and distribute all of Rosetta Genomics' testing services worldwide, the companies announced today.
The deal comes as the firms try — for the second time — to close a merger that had previously failed to gain necessary approval from Rosetta shareholders.